亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis

医学 肺结核 左氧氟沙星 养生 安慰剂 内科学 不利影响 随机对照试验 随机化 儿科 免疫学 抗生素 病理 生物 微生物学 替代医学
作者
Anneke Catharina Hesseling,Susan E. Purchase,Neil Alexander Martinson,Lee Fairlie,Hendrik Simon Schaaf,Joanna Brigden,Suzanne Staples,Diana M. Gibb,Anthony J. Garcia‐Prats,Francesca Conradie,Charlotte McGowan,Charlotte Layton,Elize Batist,Anne‐Marie Demers,Samukelisiwe Nyamathe,Lisa Jane Frigati,Rebecca Turner,Trinh Duong,James A. Seddon
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:391 (24): 2315-2326 被引量:73
标识
DOI:10.1056/nejmoa2314318
摘要

BACKGROUND: , with MDR tuberculosis developing in approximately 30,000 annually. Evidence from randomized, controlled trials on tuberculosis preventive treatment in persons exposed to MDR tuberculosis is lacking. METHODS: In this community-based, multisite, double-blind, cluster-randomized, placebo-controlled trial in South Africa, we assessed the efficacy and safety of levofloxacin as preventive treatment in children with household exposure to an adult with bacteriologically confirmed MDR pulmonary tuberculosis. Children younger than 5 years of age were eligible for inclusion regardless of interferon-γ release assay result or human immunodeficiency virus (HIV) status, and children 5 to 17 years of age were eligible if they had a positive interferon-γ release assay or HIV infection. Households were randomly assigned to a trial regimen, and children in the household received levofloxacin or placebo once daily for 24 weeks. The primary efficacy end point was incident tuberculosis, which included death from tuberculosis, by week 48 after randomization. The primary safety end point was any adverse event of grade 3 or higher during the treatment period that was at least possibly related to the trial regimen. RESULTS: Of 922 participants from 497 households, 453 were assigned to receive levofloxacin and 469 to placebo; 91.0% of the participants were younger than 5 years of age. At least 80% of the assigned doses of levofloxacin or placebo were received by 86% of the participants in each trial group. By week 48, tuberculosis had developed in 5 participants (1.1%) in the levofloxacin group and in 12 participants (2.6%) in the placebo group (hazard ratio, 0.44; 95% confidence interval [CI], 0.15 to 1.25). The results of sensitivity analyses were consistent with those of the primary analysis. Grade 3 or higher adverse events during the treatment period that were considered to be at least possibly related to the trial regimen occurred in 4 participants in the levofloxacin group and in 8 participants in the placebo group (hazard ratio, 0.52; 95% CI, 0.16 to 1.71). Grade 2 tendonitis occurred in 1 child in the levofloxacin group. CONCLUSIONS: Although preventive treatment with levofloxacin led to a lower incidence of tuberculosis than placebo among children with household exposure to MDR tuberculosis, the difference was not significant. (Supported by Unitaid and others; TB-CHAMP ISRCTN Registry number, ISRCTN92634082.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迷人白桃完成签到,获得积分10
1秒前
6秒前
楓秋完成签到 ,获得积分10
25秒前
mmyhn驳回了奔跑的应助
29秒前
爱听歌鲂完成签到,获得积分10
33秒前
46秒前
1分钟前
英俊的铭的应助被科研通管家采纳,获得10
1分钟前
忧虑的怀曼完成签到,获得积分10
1分钟前
顺心安雁完成签到,获得积分10
1分钟前
李佳佳发布了新的文献求助10
1分钟前
mmyhn驳回了奔跑的应助
1分钟前
大熊完成签到 ,获得积分10
1分钟前
qin完成签到 ,获得积分10
1分钟前
1分钟前
光亮豌豆完成签到,获得积分10
1分钟前
无私的迎蓉完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
每天吃土发布了新的文献求助10
2分钟前
奔跑的应助被mmyhn采纳,获得10
2分钟前
汉堡包的应助被每天吃土采纳,获得10
2分钟前
2分钟前
酷炫的又蓝完成签到,获得积分10
2分钟前
mmyhn发布了新的文献求助10
2分钟前
每天吃土完成签到 ,获得积分10
2分钟前
整齐的诗筠完成签到,获得积分10
2分钟前
2分钟前
沐木完成签到 ,获得积分10
2分钟前
369ninja的应助被科研通管家采纳,获得10
3分钟前
文静的惜霜完成签到,获得积分10
3分钟前
ChenYQ完成签到,获得积分10
3分钟前
虚心的迎彤完成签到,获得积分10
3分钟前
无限之桃完成签到,获得积分10
3分钟前
合适乐巧完成签到 ,获得积分10
3分钟前
舒心书白完成签到,获得积分10
4分钟前
wangfaqing942完成签到 ,获得积分10
4分钟前
无语的新之完成签到,获得积分10
4分钟前
拥抱完成签到 ,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173088
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780437
捐赠科研通 7767172
什么是DOI,文献DOI怎么找? 3431536
关于科研通互助平台的介绍 2555678
邀请新用户注册赠送积分活动 2476675